γ2-Melanocyte stimulation hormone (γ2- MSH) truncation studies results in the cautionary note that γ2- MSH is not selective for the mouse MC3R over the mouse MC5R

Peptides

Volumn 31, Issue 12, 2010, Pages 2304-2313

  Joseph, Christine G ^a   Yao, Hua ^a   Scott, Joseph W ^a   Sorensen, Nicholas B ^a   Marnane, Rebecca N ^b   Mountjoy, Kathleen G ^b   Haskell Luevano, Carrie ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Blood pressure; GPCR; Heart; Melanotropin; Obesity; Receptor brain expression

Indexed keywords

AMINO ACID; ARGININE; ASPARTIC ACID; GAMMA2 INTERMEDIN; INTERMEDIN DERIVATIVE; LIGAND; MELANOCORTIN 3 RECEPTOR; MELANOCORTIN 4 RECEPTOR; MELANOCORTIN 5 RECEPTOR; MELANOCORTIN RECEPTOR; MELANOCORTIN RECEPTOR AGONIST; MESSENGER RNA; PHENYLALANINE; SODIUM CHLORIDE; UNCLASSIFIED DRUG; ALPHA INTERMEDIN; CYCLIC AMP; DRUG DERIVATIVE; GAMMA INTERMEDIN; MC3R PROTEIN, MOUSE; MELANOCORTIN 1 RECEPTOR; MSH, 4 NLE 7 PHE ALPHA; MSH, 4-NLE-7-PHE-ALPHA-;

AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; EMBRYO; GENE EXPRESSION; HUMAN; HYPOTHALAMUS; HYPOTHESIS; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; RODENT; ANIMAL; BRAIN; CELL LINE; CHEMISTRY; DRUG EFFECT; GENETICS; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STRUCTURE ACTIVITY RELATION;

RODENTIA;

ALPHA-MSH; ANIMALS; BRAIN; CELL LINE; CYCLIC AMP; GAMMA-MSH; HUMANS; MALE; MICE; RECEPTOR, MELANOCORTIN, TYPE 1; RECEPTOR, MELANOCORTIN, TYPE 3; RECEPTOR, MELANOCORTIN, TYPE 4; RECEPTORS, MELANOCORTIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 78049482868     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2010.08.025     Document Type: Article

References (77)

1. D. Atalayer, K.L. Robertson, C. Haskell-Luevano, A. Andreasen, and N.E. Rowland Food demand and meal size in mice with single or combined disruption of melanocortin type 3 and 4 receptors Am J Physiol Regul Integr Comp Physiol 298 2010 R1667 R1674
2. M.A. Bednarek, T. MacNeil, R.N. Kalyani, R. Tang, L.H. Van Der Ploeg, and D.H. Weinberg Selective, high affinity peptide antagonists of α-melanotropin action at human melanocortin receptor 4: their synthesis and biological evaluation in vitro J Med Chem 44 2001 3665 3672
3. A.A. Butler, R.A. Kesterson, K. Khong, M.J. Cullen, M.A. Pelleymounter, and J. Dekoning A unique metabolic syndrome causes obesity in the melanocortin-3 receptor-deficient mouse Endocrinology 141 2000 3518 3521
4. M. Cai, A.V. Mayorov, C. Cabello, M. Stankova, D. Trivedi, and V.J. Hruby Novel 3D pharmacophore of alpha-MSH/gamma-MSH hybrids leads to selective human MC1R and MC3R analogues J Med Chem 48 2005 1839 1848
5. L.A. Carpino, and G.Y. Han The 9-fluorenylmethoxycarbonyl function, a new base-sensitive amino-protecting group J Am Chem Soc 92 1970 5748 5749
6. L.A. Carpino, and G.Y. Han The 9-fluorenylmethyloxycarbonyl amino-protecting group J Org Chem 37 1972 3404 3409
7. A.M.L. Castrucci, M.E. Hadley, T.K. Sawyer, B.C. Wilkes, F. Al-Obeidi, and D.J. Staples α-Melanotropin: the minimal active sequence in the lizard skin bioassay Gen Comp Endocrinol 73 1989 157 163
8. A.M.L. Castrucci, M.E. Hadley, E.I. Yorulmazoglu, B.C. Wilkes, T.K. Sawyer, and V.J. Hruby Synthesis and studies of melanotropins resistant to enzyme degradation Yale J Biol Med 57 1984 345 346
9. A.M.L. Castrucci, M.E. Hadley, E.I. Yorulmazoglu, B.C. Wilkes, T.K. Sawyer, and V.J. Hruby Synthesis and studies of superpotent melanotropins resistant to enzyme degradation J. Bagnara, S.N. Klaus, E. Paul, M. Schartl, Pigment cell 1985, biological, molecular and clinical aspects of pigmentation 1985 University of Tokyo Press 145 151
10. A.S. Chen, D.J. Marsh, M.E. Trumbauer, E.G. Frazier, X.M. Guan, and H. Yu Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass Nat Genet 26 2000 97 102
11. C.A. Chen, and H. Okayama Calcium phosphate-medicated gener transfer: a highly efficient transfections system for stably transforming cells with plasmid DNA Biotechniques 6 1988 632 638
12. W. Chen, M.A. Kelly, X. Opitz-Araya, R.E. Thomas, M.J. Low, and R.D. Cone Exocrine gland dysfunction in MC5-R deficient mice: evidence for coordinated regulation of exocrine gland functions by melanocortin peptides Cell 91 1997 789 798
13. W. Chen, T.S. Shields, P.J.S. Stork, and R.D. Cone A colorimetric assay for measuring activation of Gs- and Gq-coupled signaling pathways Anal Biochem 226 1995 349 354
14. V. Chhajlani, R. Muceniece, and J.E.S. Wikberg Molecular cloning of a novel human melanocortin receptor Biochem Biophys Res Commun 195 1993 866 873
15. V. Chhajlani, and J.E.S. Wikberg Molecular cloning and expression of the human melanocyte stimulating hormone receptor cDNA FEBS Lett 309 1992 417 420
16. B.P. Chowdhary, I. Gustavsson, J.E.S. Wikberg, and V. Chhajlani Localizaton of the human melanocortin-5 recpetor gene (MC5R) to chromosome band 18p11.2 by fluorescence in situ hybridizaiton Cytogenet Cell Genet 68 1995 79 81
17. R.D. Cone, The melanocortin receptors 2000 The Humana Press Inc. New Jersey
18. R.D. Cone, The Melanocortin System vol. 994 2003 Annals of the New York Academy of Sciences New York
19. R.D. Cone, D. Lu, S. Kopula, D.I. Vage, H. Klungland, and B. Boston The melanocortin receptors: agonists, antagonists, and the hormonal control of pigmentation Recent Progr Horm Res 51 1996 287 318
20. B.A. Eipper, and R.E. Mains Structure and biosynthesis of Pro-ACTH/endorphin and related peptides Endocrin Rev 1 1980 1 26
21. W. Fan, B.A. Boston, R.A. Kesterson, V.J. Hruby, and R.D. Cone Role of melanocortinergic neurons in feeding and the agouti obesity syndrome Nature 385 1997 165 168
22. I.S. Farooqi, G.S. Yeo, J.M. Keogh, S. Aminian, S.A. Jebb, and G. Butler Dominant and recessive inheritance of morbid obesity associated with melanocortin 4 receptor deficiency J Clin Invest 106 2000 271 279
23. I. Gantz, and T.M. Fong The melanocortin system Am J Physiol Endocrinol Metab 284 2003 E468 E474
24. I. Gantz, Y. Konda, T. Tashiro, Y. Shimoto, H. Miwa, and G. Munzert Molecular cloning of a novel melanocortin receptor J Biol Chem 268 1993 8246 8250
25. I. Gantz, H. Miwa, Y. Konda, Y. Shimoto, T. Tashiro, and S.J. Watson Molecular cloning, expression, and gene localization of a fourth melanocortin receptor J Biol Chem 268 1993 15174 15179
26. I. Gantz, Y. Shimoto, Y. Konda, H. Miwa, C.J. Dickinson, and T. Yamada Molecular cloning, expression, and characterization of a fifth melanocortin receptor Biochem Biophys Res Commun 200 1994 1214 1220
27. S.J. Getting, C.W. Lam, G. Leoni, F.N. Gavins, P. Grieco, and M. Perretti D-Trp8-gamma-melanocyte-stimulating hormone exhibits anti-inflammatory efficacy in mice bearing a nonfunctional MC1R (recessive yellow e/e mouse) Mol Pharmacol 70 2006 1850 1855
28. J.R. Greenfield, J.W. Miller, J.M. Keogh, E. Henning, J.H. Satterwhite, and G.S. Cameron Modulation of blood pressure by central melanocortinergic pathways N Engl J Med 360 2009 44 52
29. P. Grieco, P.M. Balse, D. Weinberg, T. MacNeil, and V.J. Hruby d-Amino acid scan of γ-melanocyte-stimulating hormone: importance of Trp(8) on human MC3 receptor selectivity J Med Chem 43 2000 4998 5002
30. P. Grieco, P. Balse-Srinivasan, G. Han, V.J. Hruby, D. Weinberg, and T. MacNeil Synthesis and biological evaluation on hMC3, hMC4 and hMC5 receptors of γ-MSH analogs substituted with l-alanine J Pept Res 59 2002 203 210
31. C. Haskell-Luevano, R.D. Cone, E.K. Monck, and Y.-P. Wan Structure-activity studies of the melanocortin-4 receptor by in vitro mutagenesis: identification of agouti-related protein (AGRP), melanocortin agonist and synthetic peptide antagonist interaction determinants Biochemistry 40 2001 6164 6179
32. C. Haskell-Luevano, S. Hendrata, C. North, T.K. Sawyer, M.E. Hadley, and V.J. Hruby Discovery of prototype peptidomimetic agonists at the human melanocortin receptors MC1R and MC4R J Med Chem 40 1997 2133 2139
33. 2, on human melanocortin receptors J Med Chem 40 1997 1738 1748
34. C. Haskell-Luevano, J.W. Schaub, A. Andreasen, K.R. Haskell, M.C. Moore, and L.M. Koerper Voluntary exercise prevents the obese and diabetic metabolic syndrome of the melanocortin-4 receptor knockout mouse FASEB J 23 2009 642 655
35. A. Hinney, A. Schmidt, K. Nottebom, O. Heibult, I. Becker, and A. Ziegler Several mutations in the melanocortin-4 receptor gene including a nonsense and a frameshift mutation associated with dominantly inherited obesity in humans J Clin Endocrinol Metab 84 1999 1483 1486
36. 2 at the mouse melanocortin receptors: Part 2. Modifications at the Phe position J Med Chem 45 2002 3073 3081
37. 2 with bulky aromatic amino acids at position 7 show high antagonist potency and selectivity at specific melanocortin receptors J Med Chem 38 1995 3454 3461
38. V.J. Hruby, B.C. Wilkes, W.L. Cody, T.K. Sawyer, and M.E. Hadley Melanotropins: structural, conformational and biological considerations in the development of superpotent and superprolonged analogs Peptide Protein Rev 3 1984 1 64
39. V.J. Hruby, B.C. Wilkes, M.E. Hadley, F. Al-Obeidi, T.K. Sawyer, and D.J. Staples α-Melanotropin: the minimal active sequence in the frog skin bioassay J Med Chem 30 1987 2126 2130
40. M.H. Humphreys ©-MSH, sodium metabolism, and salt-sensitive hypertension Am J Physiol Regul Integr Comp Physiol 286 2004 R417 430
41. M.H. Humphreys Cardiovascular and renal actions of melanocyte-stimulating hormone peptides Curr Opin Nephrol Hypertens 16 2007 32 38
42. D. Huszar, C.A. Lynch, V. Fairchild-Huntress, J.H. Dunmore, F.J. Smith, and R.A. Kesterson Targeted disruption of the melanocortin-4 receptor results in obesity in mice Cell 88 1997 131 141
43. B.G. Irani, J.R. Holder, A. Todorovic, A.M. Wilczynski, C.G. Joseph, and K.R. Wilson Progress in the development of melanocortin receptor selective ligands Curr Pharm Des 10 2004 3443 3479
44. B.G. Irani, Z. Xiang, M.C. Moore, R.J. Mandel, and C. Haskell-Luevano Voluntary exercise delays monogenetic obesity and overcomes reproductive dysfunction of the melanocortin-4 receptor knockout mouse Biochem Biophys Res Commun 326 2005 638 644
45. C.G. Joseph, R.M. Bauzo, Z. Xiang, A.M. Shaw, W.J. Millard, and C. Haskell-Luevano Elongation studies of the human agouti-related protein (AGRP) core decapeptide (Yc[CRFFNAFC]Y) results in antagonism at the mouse melanocortin-3 receptor Peptides 27 2003 263 270
46. E. Kaiser, R.L. Colescott, C.D. Bossinger, and P.I. Cook Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides Anal Biochem 34 1970 595 598
47. A. Kask, F. Mutulis, R. Muceniece, R. Pahkla, I. Mutule, and J.E. Wikberg Discovery of a novel superpotent and selective melanocortin-4 receptor antagonist (HS024): evaluation in vitro and in vivo Endocrinology 139 1998 5006 5014
48. L.L. Kiefer, O.R. Ittoop, K. Bunce, A.T. Truesdale, D.H. Willard, and J.S. Nichols Mutations in the carboxyl terminus of the agouti protein decrease agouti inhibition of ligand binding to the melanocortin receptors Biochemistry 36 1997 2084 2090
49. T. Kishi, C.J. Aschkenasi, C.E. Lee, K.G. Mountjoy, C.B. Saper, and J.K. Elmquist Expression of melanocortin 4 receptor mRNA in the central nervous system of the rat J Comp Neurol 457 2003 213 235
50. A.B. Lerner, and J.S. McGuire Effect of alpha- and beta-melanocyte stimulating hormones on the skin colour of man Nature 189 1961 176 179
51. S.-J. Li, K. Varga, P. Archer, V.J. Hruby, S.D. Sharma, and R.A. Kesterson Melanocrotin antagonists define two distinct pathways of cardiovascular control by α- and γ-melanocyte-stimulating hormones J Neurosci 16 1996 5182 5188
52. D. Lu, D.I. Väge, and R.D. Cone A ligand-mimetic model for constitutive activation of the melanocortin-1 receptor Mol Endocrinol 12 1998 592 604
53. D. Lu, D. Willard, I.R. Patel, S. Kadwell, L. Overton, and T. Kost Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptor Nature 371: 1994 799 802
54. D.L. Marks, V. Hruby, G. Brookhart, and R.D. Cone The regulation of food intake by selective stimulation of the type 3 melanocortin receptor (MC3R) Peptides 27 2006 259 264
55. N.M. Martin, C.J. Small, A. Sajedi, M. Patterson, M.A. Ghatei, and S.R. Bloom Pre-obese and obese agouti mice are sensitive to the anorectic effects of peptide YY(3-36) but resistant to ghrelin Int J Obes Relat Metab Disord 28 2004 886 893
56. K. Medzihradszky The bio-organic chemistry of α-melanotropin Med Res Rev 2 1982 247 270
57. K.G. Mountjoy, M.T. Mortrud, M.J. Low, R.B. Simerly, and R.D. Cone Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain Mol Endocrinol 8 1994 1298 1308
58. K.G. Mountjoy, L.S. Robbins, M.T. Mortrud, and R.D. Cone The cloning of a family of genes that encode the melanocortin receptors Science 257 1992 1248 1251
59. X.P. Ni, A.A. Butler, R.D. Cone, and M.H. Humphreys Central receptors mediating the cardiovascular actions of melanocyte stimulating hormones J Hypertens 24 2006 2239 22346
60. M.J. Nijsen, G.J. de Ruiter, C.M. Kasbergen, P. Hoogerhout, and D.J. de Wildt Relevance of the C-terminal Arg-Phe sequence in gamma(2)-melanocyte- stimulating hormone (gamma(2)-MSH) for inducing cardiovascular effects in conscious rats Br J Pharmacol 131 2000 1468 1474
61. M.M. Ollmann, B.D. Wilson, Y.-K. Yang, J.A. Kerns, Y. Chen, and I. Gantz Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein Science 278 1997 135 138
62. L.E. Pritchard, A.V. Turnbull, and A. White Pro-opiomelanocortin processing in the hypothalamus: impact on melanocortin signalling and obesity J Endocrinol 172 2002 411 421
63. L.E. Pritchard, and A. White Neuropeptide processing and its impact on melanocortin pathways Endocrinology 148 2007 4201 4207
64. L. Roselli-Rehfuss, K.G. Mountjoy, L.S. Robbins, M.T. Mortrud, M.J. Low, and J.B. Tatro Identification of a receptor for γ melanotropin and other proopiomelanocortin peptides in the hypothalamus and limbic system Proc Natl Acad Sci U S A 90 1993 8856 8860
65. T.K. Sawyer, P.J. Sanfillippo, V.J. Hruby, M.H. Engel, C.B. Heward, and J.B. Burnett 4-Norleucine, 7-d-phenylalanine-α-melanocyte-stimulating hormone: a highly potent α-melanotropin with ultra long biological activity Proc Natl Acad Sci U S A 77 1980 5754 5758
66. M. Sina, A. Hinney, A. Ziegler, T. Neupert, H. Mayer, and W. Siegfried Phenotypes in three pedigrees with autosomal dominant obesity caused by haploinsufficiency mutations in the melanocortin-4 receptor gene Am J Hum Genet 65 1999 1501 1507
67. A.I. Smith, and J.W. Funder Proopiomelanocortin processing in the pituitary, central nervous system and peripheral tissues Endocrin Rev 9 1988 159 179
68. A. Todorovic, C.G. Joseph, N.B. Sorensen, M.S. Wood, and C. Haskell-Luevano Structure-activity relationships of melanocortin agonists containing the benzimidazole scaffold Chem Biol Drug Des 69 2007 338 349
69. C. Vaisse, K. Clement, E. Durand, S. Hercberg, B. Guy-Grand, and P. Froguel Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity J Clin Invest 106 2000 253 262
70. C. Vaisse, K. Clement, B. Guy-Grand, and P. Froguel A frameshift mutation in human MC4R is associated with a dominant form of obesity Nat Genet 20 1998 113 114
71. P. Van Bergen, P.M. Janssen, P. Hoogerhout, D.J. De Wildt, and D.H. Versteeg Cardiovascular effects of gamma-MSH/ACTH-like peptides: structure-activity relationship Eur J Pharmacol 294 1995 795 803
72. P. Van Bergen, J.A. Kleijne, D.J. De Wildt, and D.H. Versteeg Different cardiovascular profiles of three melanocortins in conscious rats; evidence for antagonism between gamma 2-MSH and ACTH-(1-24) Br J Pharmacol 120 1997 1561 1567
73. P. Van Bergen, J.G. Van Der Vaart, C.M. Kasbergen, D.H. Versteeg, and D.J. De Wildt Structure-activity analysis for the effects of gamma-MSH/ACTH-like peptides on cerebral hemodynamics in rats Eur J Pharmacol 318 1996 357 368
74. L.H. Van Der Ploeg, W.J. Martin, A.D. Howard, R.P. Nargund, C.P. Austin, and X. Guan A role for the melanocortin 4 receptor in sexual function Proc Natl Acad Sci U S A 99 2002 11381 11386
75. D.H.G. Versteeg, P. Van Bergen, R.A.H. Adan, and D.J. De Wildt Melanocortins and cardiovascular regulation Eur J Pharmacol 360 1998 1 14
76. H. Wessells, K. Fuciarelli, J. Hansen, M.E. Hadley, V.J. Hruby, and R. Dorr Synthetic melanotropic peptide initiates erections in men with psychogenic erectile dysfunction: double-blind, placebo controlled crossover study J Urol 160 1998 389 393
77. Y.-K. Yang, M.M. Ollmann, B.D. Wilson, C. Dickinson, T. Yamada, and G.S. Barsh Effects of recombinant agouti signaling protein on melanocortin action Mol Endocrinol 11 1997 274 280